Literature DB >> 21611798

A method to generate recombinant Salmonella typhi Ty21a strains expressing multiple heterologous genes using an improved recombineering strategy.

Bin Yu1, Mei Yang, Ho Yin Bosco Wong, Rory M Watt, Erwei Song, Bo-Jian Zheng, Kwok-Yung Yuen, Jian-Dong Huang.   

Abstract

Live attenuated Salmonella enterica serovar Typhi Ty21a (Ty21a) is an important vaccine strain used in clinical studies for typhoid fever and as a vaccine vector for the expression of heterologous antigens. To facilitate the use of Ty21a in such studies, it is desirable to develop improved strategies that enable the stable chromosomal integration and expression of multiple heterologous antigens. The phage λ Red homologous recombination system has previously been used in various gram-negative bacteria species to mediate the accurate replacement of regions of chromosomal DNA with PCR-generated 'targeting cassettes' that contain flanking regions of shared homologous DNA sequence. However, the efficiency of λ Red-mediated recombineering in Ty21a is far lower than in Escherichia coli and other Salmonella typhimurium strains. Here, we describe an improved strategy for recombineering-based methods in Ty21a. Our reliable and efficient method involves the use of linear DNA-targeting cassettes that contain relatively long flanking 'arms' of sequence (ca. 1,000 bp) homologous to the chromosomal target. This enables multiple gene-targeting procedures to be performed on a single Ty21a chromosome in a straightforward, sequential manner. Using this strategy, we inserted three different influenza antigen expression cassettes as well as a green fluorescent protein gene reporter into four different loci on the Ty21a chromosome, with high efficiency and accuracy. Fluorescent microscopy and Western blotting analysis confirmed that strong inducible expression of all four heterologous genes could be achieved. In summary, we have developed an efficient, robust, and versatile method that may be used to construct recombinant Ty21a antigen-expressing strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21611798     DOI: 10.1007/s00253-011-3317-0

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  4 in total

1.  Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines.

Authors:  Song-yue Zheng; Bin Yu; Ke Zhang; Min Chen; Yan-Hong Hua; Shuofeng Yuan; Rory M Watt; Bo-Jian Zheng; Kwok-Yung Yuen; Jian-Dong Huang
Journal:  BMC Immunol       Date:  2012-09-26       Impact factor: 3.615

2.  Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.

Authors:  Bin Yu; Mei Yang; Lei Shi; Yandan Yao; Qinqin Jiang; Xuefei Li; Lei-Han Tang; Bo-Jian Zheng; Kwok-Yung Yuen; David K Smith; Erwei Song; Jian-Dong Huang
Journal:  Sci Rep       Date:  2012-06-01       Impact factor: 4.379

3.  Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.

Authors:  Karen Roos; Esther Werner; Holger Loessner
Journal:  Microb Biotechnol       Date:  2014-12-09       Impact factor: 5.813

4.  Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection.

Authors:  Chen Xu; Bao-Zhong Zhang; Qiubin Lin; Jian Deng; Bin Yu; Smriti Arya; Kwok-Yung Yuen; Jian-Dong Huang
Journal:  BMC Infect Dis       Date:  2018-04-25       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.